Akoya Biosciences, Inc. – NASDAQ:AKYA
Akoya Biosciences stock price today
$1.29
-1.10
-46.03%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 1 hour
Akoya Biosciences stock price monthly change
+3.46%
month
Akoya Biosciences stock price quarterly change
+3.46%
quarter
Akoya Biosciences stock price yearly change
-53.41%
year
Akoya Biosciences key metrics
Market Cap | 115.98M |
Enterprise value | 275.22M |
P/E | -3.98 |
EV/Sales | 3.67 |
EV/EBITDA | -4.67 |
Price/Sales | 3.65 |
Price/Book | 4.67 |
PEG ratio | 0.29 |
EPS | -1.47 |
Revenue | 93.57M |
EBITDA | -50.73M |
Income | -68.00M |
Revenue Q/Q | -14.29% |
Revenue Y/Y | 17.88% |
Profit margin | -94.37% |
Oper. margin | -88.44% |
Gross margin | 57.96% |
EBIT margin | -88.44% |
EBITDA margin | -54.22% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAkoya Biosciences stock price history
Akoya Biosciences stock forecast
Akoya Biosciences financial statements
Average Price Target
$3.5
Potential upside: 171.33%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 23.52M | -20.80M | -88.44% |
|---|---|---|---|
| Sep 2023 | 25.21M | -12.91M | -51.22% |
| Dec 2023 | 26.48M | -10.80M | -40.78% |
| Mar 2024 | 18.35M | -23.48M | -127.98% |
| 2024-03-04 | -0.27 | -0.22 |
|---|
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | 0.25% |
| 2022 | |
| 2023 |
| Jun 2023 | 188879000 | 116.97M | 61.93% |
|---|---|---|---|
| Sep 2023 | 177244000 | 115.27M | 65.04% |
| Dec 2023 | 180369000 | 126.59M | 70.19% |
| Mar 2024 | 154750000 | 122.02M | 78.85% |
| Jun 2023 | -11.80M | -1.42M | 46.32M |
|---|---|---|---|
| Sep 2023 | -13.75M | -832K | -141K |
| Dec 2023 | -5.55M | -594K | 11.04M |
| Mar 2024 | -20.82M | -48.81M | -444K |
Akoya Biosciences alternative data
| Aug 2023 | 369 |
|---|---|
| Sep 2023 | 369 |
| Oct 2023 | 369 |
| Nov 2023 | 369 |
| Dec 2023 | 369 |
| Jan 2024 | 369 |
| Feb 2024 | 369 |
| Mar 2024 | 330 |
| Apr 2024 | 330 |
| May 2024 | 330 |
| Jun 2024 | 330 |
| Jul 2024 | 330 |
Akoya Biosciences other data
8.88%
-28.24%
of AKYA is owned by hedge funds
31
-40
3.35M
-10.71M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2023 | 20000 | 0 |
| Nov 2023 | 0 | 7500 |
| Dec 2023 | 0 | 15000 |
| Mar 2024 | 0 | 22500 |
| Jun 2024 | 0 | 15000 |
| Patent |
|---|
Application Filling date: 14 Apr 2022 Issue date: 4 Aug 2022 |
Application Filling date: 18 Nov 2021 Issue date: 19 May 2022 |
Application Filling date: 4 Feb 2020 Issue date: 28 Apr 2022 |
Application Filling date: 26 Aug 2021 Issue date: 3 Mar 2022 |
Application Filling date: 20 Jul 2021 Issue date: 20 Jan 2022 |
Application Filling date: 30 Sep 2020 Issue date: 22 Jul 2021 |
Application Filling date: 28 Jan 2021 Issue date: 20 May 2021 |
Grant Filling date: 7 Jan 2014 Issue date: 30 Mar 2021 |
Application Filling date: 15 Jun 2020 Issue date: 17 Dec 2020 |
Application Filling date: 21 Oct 2019 Issue date: 23 Apr 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 17 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 4 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 11 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Brian McKelligon (1969) Pres, Chief Executive Officer & Director | $407,750 |
| Mr. Joseph S. Driscoll (1965) Chief Financial Officer | $364,620 |
| Dr. Niro Ramachandran Ph.D. (1975) Chief Bus. Officer | $298,180 |
Liquidia Continues To Expand Their Growth Vs. MannKind's Growth In Share Prices
Strong Small-Cap Insider Buys: Q2 2023
Akoya Bioscience: Something Special For Investing In A Spatial Bioscience Company
Biopharmaceutical Stocks Continue To Perform Well, With Many Attractive Values Remaining
U.S. IPO Weekly Recap: Coinbase's Direct Listing Headlines A 9 IPO Week
-
What's the price of Akoya Biosciences stock today?
One share of Akoya Biosciences stock can currently be purchased for approximately $1.29.
-
When is Akoya Biosciences's next earnings date?
Unfortunately, Akoya Biosciences's (AKYA) next earnings date is currently unknown.
-
Does Akoya Biosciences pay dividends?
No, Akoya Biosciences does not pay dividends.
-
How much money does Akoya Biosciences make?
Akoya Biosciences has a market capitalization of 115.98M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 29.09% to 96.63M US dollars. Akoya Biosciences made a loss 63.32M US dollars in net income (profit) last year or -$0.22 on an earnings per share basis.
-
What is Akoya Biosciences's stock symbol?
Akoya Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "AKYA".
-
What is Akoya Biosciences's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Akoya Biosciences?
Shares of Akoya Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Akoya Biosciences's key executives?
Akoya Biosciences's management team includes the following people:
- Mr. Brian McKelligon Pres, Chief Executive Officer & Director(age: 56, pay: $407,750)
- Mr. Joseph S. Driscoll Chief Financial Officer(age: 60, pay: $364,620)
- Dr. Niro Ramachandran Ph.D. Chief Bus. Officer(age: 50, pay: $298,180)
-
How many employees does Akoya Biosciences have?
As Jul 2024, Akoya Biosciences employs 330 workers.
-
When Akoya Biosciences went public?
Akoya Biosciences, Inc. is publicly traded company for more then 4 years since IPO on 16 Apr 2021.
-
What is Akoya Biosciences's official website?
The official website for Akoya Biosciences is akoyabio.com.
-
Where are Akoya Biosciences's headquarters?
Akoya Biosciences is headquartered at 100 Campus Drive, Marlborough, MA.
-
How can i contact Akoya Biosciences?
Akoya Biosciences's mailing address is 100 Campus Drive, Marlborough, MA and company can be reached via phone at +855 8968401.
-
What is Akoya Biosciences stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for Akoya Biosciences in the last 12 months, the avarage price target is $3.5. The average price target represents a 171.33% change from the last price of $1.29.
Akoya Biosciences company profile:
Akoya Biosciences, Inc.
akoyabio.comExchange:
NASDAQ
Full time employees:
330
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
100 Campus Drive
Marlborough, MA 01752
Marlborough, MA 01752
CIK: 0001711933
ISIN: US00974H1041
CUSIP: 00974H104
